miRNAs as potential therapeutic targets for age-related macular degeneration

Shusheng Wang, Kyle M. Koster, Yuguang He, Qinbo Zhou

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Since their recent discovery, miRNAs have been shown to play critical roles in a variety of pathophysiological processes. Such processes include pathological angiogenesis, the oxidative stress response, immune response and inflammation, all of which have been shown to have important and interdependent roles in the pathogenesis and progression of age-related macular degeneration (AMD). Here we present a brief review of the pathological processes involved in AMD and review miRNAs and other noncoding RNAs involved in regulating these processes. Specifically, we discuss several candidate miRNAs that show promise as AMD therapeutic targets due to their direct involvement in choroidal neovascularization or retinal pigment epithelium atrophy. We discuss potential miRNA-based therapeutics and delivery methods for AMD and provide future directions for the field of miRNA research with respect to AMD. We believe the future of miRNAs in AMD therapy is promising.

Original languageEnglish (US)
Pages (from-to)277-287
Number of pages11
JournalFuture Medicinal Chemistry
Volume4
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

Macular Degeneration
MicroRNAs
Therapeutics
Pathologic Neovascularization
Choroidal Neovascularization
Untranslated RNA
Retinal Pigment Epithelium
Pathologic Processes
Atrophy
Oxidative Stress
Inflammation
Research

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Molecular Medicine

Cite this

miRNAs as potential therapeutic targets for age-related macular degeneration. / Wang, Shusheng; Koster, Kyle M.; He, Yuguang; Zhou, Qinbo.

In: Future Medicinal Chemistry, Vol. 4, No. 3, 03.2012, p. 277-287.

Research output: Contribution to journalArticle

Wang, Shusheng ; Koster, Kyle M. ; He, Yuguang ; Zhou, Qinbo. / miRNAs as potential therapeutic targets for age-related macular degeneration. In: Future Medicinal Chemistry. 2012 ; Vol. 4, No. 3. pp. 277-287.
@article{6cf1b2e24ba0474393b6856a5dbef3b2,
title = "miRNAs as potential therapeutic targets for age-related macular degeneration",
abstract = "Since their recent discovery, miRNAs have been shown to play critical roles in a variety of pathophysiological processes. Such processes include pathological angiogenesis, the oxidative stress response, immune response and inflammation, all of which have been shown to have important and interdependent roles in the pathogenesis and progression of age-related macular degeneration (AMD). Here we present a brief review of the pathological processes involved in AMD and review miRNAs and other noncoding RNAs involved in regulating these processes. Specifically, we discuss several candidate miRNAs that show promise as AMD therapeutic targets due to their direct involvement in choroidal neovascularization or retinal pigment epithelium atrophy. We discuss potential miRNA-based therapeutics and delivery methods for AMD and provide future directions for the field of miRNA research with respect to AMD. We believe the future of miRNAs in AMD therapy is promising.",
author = "Shusheng Wang and Koster, {Kyle M.} and Yuguang He and Qinbo Zhou",
year = "2012",
month = "3",
doi = "10.4155/fmc.11.176",
language = "English (US)",
volume = "4",
pages = "277--287",
journal = "Future Medicinal Chemistry",
issn = "1756-8919",
publisher = "Future Science",
number = "3",

}

TY - JOUR

T1 - miRNAs as potential therapeutic targets for age-related macular degeneration

AU - Wang, Shusheng

AU - Koster, Kyle M.

AU - He, Yuguang

AU - Zhou, Qinbo

PY - 2012/3

Y1 - 2012/3

N2 - Since their recent discovery, miRNAs have been shown to play critical roles in a variety of pathophysiological processes. Such processes include pathological angiogenesis, the oxidative stress response, immune response and inflammation, all of which have been shown to have important and interdependent roles in the pathogenesis and progression of age-related macular degeneration (AMD). Here we present a brief review of the pathological processes involved in AMD and review miRNAs and other noncoding RNAs involved in regulating these processes. Specifically, we discuss several candidate miRNAs that show promise as AMD therapeutic targets due to their direct involvement in choroidal neovascularization or retinal pigment epithelium atrophy. We discuss potential miRNA-based therapeutics and delivery methods for AMD and provide future directions for the field of miRNA research with respect to AMD. We believe the future of miRNAs in AMD therapy is promising.

AB - Since their recent discovery, miRNAs have been shown to play critical roles in a variety of pathophysiological processes. Such processes include pathological angiogenesis, the oxidative stress response, immune response and inflammation, all of which have been shown to have important and interdependent roles in the pathogenesis and progression of age-related macular degeneration (AMD). Here we present a brief review of the pathological processes involved in AMD and review miRNAs and other noncoding RNAs involved in regulating these processes. Specifically, we discuss several candidate miRNAs that show promise as AMD therapeutic targets due to their direct involvement in choroidal neovascularization or retinal pigment epithelium atrophy. We discuss potential miRNA-based therapeutics and delivery methods for AMD and provide future directions for the field of miRNA research with respect to AMD. We believe the future of miRNAs in AMD therapy is promising.

UR - http://www.scopus.com/inward/record.url?scp=84863247480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863247480&partnerID=8YFLogxK

U2 - 10.4155/fmc.11.176

DO - 10.4155/fmc.11.176

M3 - Article

VL - 4

SP - 277

EP - 287

JO - Future Medicinal Chemistry

JF - Future Medicinal Chemistry

SN - 1756-8919

IS - 3

ER -